Guido Appenzeller, Ph.D.
Maximilian Ardelt
Prof. Dr. med. Carsten Bokemeyer
Prof. Dr. med. Hans-Peter Bruch
Ronald Cape, PhD
Prof. Dr. med. Jochen Cremer
William Dearstyne
Prof. Dr. med. Manfred Dreyer
Prof. Dr. med. Norbert Frey
Fritz Frickel, PhD
Ted Goldstein
Inder-Jeet Gujral
Prof. Dr. med. Friedrich Hagenmüller
Prof. Dr. med. Henry F.H. Halm
Renate Harrington
Alan C. Mendelson, JD
Mike Mueller
Prof. Dr. med. Joachim M. Müller
Jeffrey Pfeffer, Ph.D.
Jean Paul Schmetz
Tom Schulz
Prof. Dr. med. Detlef Steiner
Elena Wolff-Holz, MD, PhD
Dr. Margaret Withgott
|
WILLIAM DEARSTYNE
William Dearstyne spent 26 years with Johnson & Johnson. He was a member of the Medical Devices & Diagnostics Group Operating Committee and Company Group Chairman for all J&J Professional Products companies in the Asia/Pacific region until April, 2003.
From 1990 - 1994 he was Company Group Chairman for J&J Interventional Systems and during this time he launched the breakthrough Palmaz-Schatz Stent that revolutionized the treatment of coronary artery disease. He led two $ 1+ Billion acquisitions for J&J - Cordis and DePuy, both of which now occupy leadership positions in interventional cardiology & orthopaedics respectively.
He brings tremendous experience in managing for growth health care firms of all sizes on a global scale. Bill lives in Europe & the US. He is a Board member of Flamel Technologies (NASDAQ FLML) headquartered in France and of Phonak AG (SWX PHBN) based in Switzerland.
|
